V. S. Luchin

V. S. Luchin

Auto-generated profile, based on publicly available information

V. S. Luchin

LLC «Queisser Pharma

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2022 in Russian Ophthalmological Journal
Verified
Journal Article
Open access
PDF file
MFM. A. Frolov
M. A. Frolov
KKK. A. Kazakova
K. A. Kazakova
NSN. A. Sakhovskaya
N. A. Sakhovskaya
VLV. S. Luchin
V. S. Luchin
Purpose: to assess the effect of the biologically active additive complexes “Doppelherz® active Vitamins for eyes with lutein” and “Doppelherz® active Vitamins for eyes with chromium, zinc and selenium” on the functional state of the eye in patients with chronic ischemic optic neuropathy (ION).Material and methods. The study involved 60 patients (111 eyes) aged 51–92 (ave. 62.2 ± 1.2 yrs) with chronic ION divided into three groups of 20 patients each. Group I received the first additive, “Doppelherz® active Vitamins for eyes with lutein”; Group II received the second additive, “Doppelherz® active Vitamins for eyes with chromium, zinc and selenium”; and Group III receive no additives at all. The additives were taken according to the standard scheme — 1 tab per os during the first meal for 2 months. All patients were examined before the start and 2 months hereafter.Results. A positive trend in best corrected visual activity (BCVA) were noted in groups I and II. Group I showed an increase in the critical flicker frequency (CFF) of the red and blue spectra by 1.06 and 1.33 %, respectively, a decrease in the green spectrum by 2.7 % (p < 0.05), and an improvement in the visual fields by 0.61 %. Group II demonstrated an increase in the CFF of the red spectrum by 1.2 %, green — by 2.7 %, blue — by 0.8 %, and an improvement in visual fields by 3.08 %. Group III showed a negative trend in visual functions: BCVA dropped by 1.92 %, and CFF decreased in the green and blue spectra by 3.34 % (p < 0.05) and 0.1 %, respectively. Retinal photosensitivity improved in group I by 0.31 %, in group II by 0.59 % (p < 0.05), in group III it dropped by 0.56 %. A survey showed a decrease in asthenic and asthenopic complaints by patients of groups I and II.Conclusion. A positive effect of both biologically active additive complexes on the functional state of the eye has been revealed.

7 August 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
MFM. A. Frolov
M. A. Frolov
NSN. A. Sakhovskaya
N. A. Sakhovskaya
KKK. A. Kazakova
K. A. Kazakova
VLV. S. Luchin
V. S. Luchin
TGT. I. Gavrilenko
T. I. Gavrilenko
Introduction. According to ophthalmologists, the number of patients with signs of asthenia and asthenopia has increased substantially over the past few years. It is a known fact that good nutrition, adequate intake of vitamins and minerals with diet, compliance with work-rest regime is a necessary condition for the prevention and elimination of clinical presentations of these pathologies.Aim. To assess the results of the use of biologically active food additives Doppelherz® Kinder Omega-3 for children from 7 years old and Doppelgerz® Kinder multivitamins for children in paediatric population with signs of asthenia and asthenopia.Materials and methods. A total of 90 children aged 7-12 years with signs of reactive asthenia and asthenopia were included in the study. Patients in group 1 received the biologically active food additive Doppelherz® Kinder Omega-3 for children from 7 years old; patients in group 2 – Doppelgerz® Kinder multivitamins for children; patients in group 3 – did not receive any biologically active food additives or vitamins.Results. The CISS questionnaire showed a reduction in the severity of signs of asthenopia in group 1, less pronounced reduction of signs in group 2, and insignificant reduction in group 3. The Swanson scale showed a decrease in the degree of inattention in group 1, a decrease in the degree of inattention and impulsivity in group 2. I.K. Shats questionnaire showed that asthenia decreased from severe to moderate in group 1, and from severe to a fatigue reaction in group 2. In all groups that complied with the general recommendations, an increase in the relative accommodation reserve was observed. Evidence from pupillography indicates decreased accommodation tension, which was more pronounced in group 2 as compared with group 1, and insignificant in group 3. The Norn test and the tear meniscus height values confirmed an improvement in the tear film status, which was more pronounced in group 1 than in group 2.Discussion. There are three main directions of the treatment strategy for asthenia: etiopathogenetic, nonspecific and symptomatic therapy. Targeted addition of vitamin and mineral complexes to a child’s diet is a reasonable and integral part of the pathogenetic treatment of asthenia and asthenopia.Conclusion. A decrease in signs of asthenopia, improvement of the tear film state, reduction in signs of inattention due to increased concentration, and improvement of memory was observed in the group of patients who used the biologically active food additives with omega-3 for children from 7 years old, as compared to the control group. A decrease in signs of asthenia, and improvement of the tear film state was observed in the group of patients who used multivitamins for children — chew strips with raspberry flavour.

28 June 2024 in Clinical Dentistry (Russia)
Verified
Journal Article
Open access
PDF file
ASAndrei Sevbitov
Andrei Sevbitov
ВЛВ.с. Лучин
В.с. Лучин
ADAleksei Dorofeev
Aleksei Dorofeev
В России около 20—30% людей старше 65 лет носят съемные зубные протезы. Обычно их изготавливают из материалов, на которых могут накапливаться остатки пищи — питательная среда для бактерий. Одним из средств для ухода за протезами являются очищающие таблетки Protefix. При растворении в воде они выделяют перекись водорода и, по заявлению производителя, эффективно удаляют зубной налет, не разрушая материал протеза, уничтожая практически все болезнетворные микроорганизмы. Цель — оценить эффективность очищающих таблеток Protefix у пациентов, пользующихся частичными съемными зубными протезами. В исследовании приняли участие 40 пациентов от 60 до 74 лет, не применявших специальные средства для ухода за протезами. Пациенты I группы (n=20) начали пользоваться очищающими таблетками Protefix, пациенты II группы продолжали уход за протезами прежним образом. Измеряли индекс чистоты протеза (ИЧП) по методу Улитовского—Леонтьева (2008) до исследования и через 30 дней. До исследования ИЧП в обеих группах был равен 4,25 (плохой уровень чистоты). Через 30 дней у пациентов I группы ИЧП снизился до 2,02 (хороший уровень), в то время как во II группе он снизился незначительно (до 4,40). Применение очищающих таблеток Protefix повышает качество гигиенического ухода за ортопедическими конструкциями. Пациенты отметили удобство применения, устранение неприятных запахов и улучшение внешнего вида протезов. Очищающие таблетки Protefix могут быть рекомендованы для повседневного использования. Approximately 20—30% of people over the age of 65 in Russia wear removable dentures. They are usually made of materials that can collect food particles — a breeding ground for bacteria. Protefix cleaning tablets, based on sodium perborate with potassium peroxomonosulphate, are one of the ways to care for dentures. When dissolved in water, they release hydrogen peroxide and, according to the manufacturer, effectively remove plaque without damaging the denture material and destroy almost all pathogens. The aim was to evaluate the efficacy of Protefix cleaning tablets in patients with partially removable dentures. . The study included 40 patients aged between 60 and 74 years who did not use any special care products. Group I patients (n=20) started using Protefix cleaning tablets, group II patients continued to care for their dentures in the same way. The Denture Cleanliness Index (DCI) was measured before the study and after 30 days according to the method of Ulitovsky—Leontiev (2008). . Before the study, the DCI in both groups was 4.25 (poor cleanliness). After 30 days, the HDI decreased to 2.02 (good level of cleanliness) in group I patients, while it decreased insignificantly (to 4.40) in group II patients. . The use of Protefix cleaning tablets for removable dentures improves the quality of hygienic care of prosthetic constructions. Patients noted the convenience of use, elimination of unpleasant odours and improvement in the appearance of dentures. Protefix cleansing tablets can be recommended for daily use by patients with removable dentures.

21 May 2025 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
ASAndrei Sevbitov
Andrei Sevbitov
VLV. S. Luchin
V. S. Luchin
ADA. E. Dororfeev
A. E. Dororfeev
Relevance. An increase in life expectancy and, as a result, an increase in the proportion of the elderly population. Many people lose their teeth with age for one reason or another. This, in turn, increases the demand for removable dentures. Removable dentures take a long time to adapt, and also sometimes cause some discomfort during their operation. In order to increase the comfort of wearing removable dentures, many people use various adhesives. There are many different adhesive creams, pads, and powders on the market, which makes it difficult for patients to choose them. Currently, a new generation adhesive cream and Protefix fixing pads have appeared, which have unique properties.Goal. To compare the effect of Protefix Premium 7 adhesive cream and Protefix fixing pads on the quality of life of patients with complete removable dentures.Materials and methods. The study involved 52 male and female patients aged 75 to 90 years. The study included patients using full removable dentures on the upper jaw. During the initial examination, all patients underwent a quality of life assessment using the validated OHIP-14 questionnaire used to assess the quality of life of dental patients. Next, all patients were randomly divided into two equal groups of 26 people. In group 1, all patients were prescribed Protefix Premium 7 adhesive cream, and in group 2, patients were prescribed Protefix fixing pads for daily use. Patients were familiarized with the manufacturer’s instructions and given individual recommendations on the use of prosthetic fixation devices. A second assessment of the quality of life was carried out 30 days after the start of the study.Results and discussion. Statistically significant differences in the dynamics of quality of life were obtained after the start of using Protefix adhesives. There were no significant differences between the use of adhesive cream and Protefix fixing pads. Regardless of the presence or absence of experience in using other adhesives, there was also a positive trend in the quality of life.Conclusions. The premium adhesive cream of the new generation Protefix Premium 7 and the Protefix fixing pads meet all the declared characteristics of the manufacturer and thereby improve the quality of life of patients using complete removable dentures. The new generation Protefix Premium 7 adhesive cream and Protefix fixing pads can be recommended for daily use by patients with complete removable dentures to improve their quality of life.

20 March 2024 in Clinical Dentistry (Russia)
Verified
Journal Article
Open access
PDF file
ASAndrei Sevbitov
Andrei Sevbitov
ВЛВ.с. Лучин
В.с. Лучин
ADAleksei Dorofeev
Aleksei Dorofeev
Для повышения комфорта ношения съемных зубных протезов используют различные адгезивные кремы. На рынке присутствует множество их различных видов, что затрудняет выбор для пациентов. Сейчас появился фиксирующий крем нового поколения Протефикс Premium, который обладает семью важными свойствами. Цель — оценить влияние премиального фиксирующего крема нового поколения Протефикс Premium на качество жизни пациентов со съемными зубными протезами. В исследовании приняли участие 83 пациента от 60 до 74 лет с частичной или полной адентией, использующих частичные или полные зубные протезы. Всем пациентам для повседневного использования назначали фиксирующий крем Протефикс Premium. Оценивали динамику качества жизни пациентов в начале исследования и спустя 30 дней применения Протефикс Premium. Качество жизни определяли по опроснику OHIP-14 оценки качества жизни стоматологических пациентов. Получены статистически значимые различия в динамике качества жизни в зависимости от типа конструкции на верхней и нижней челюсти (p=0,004 и p=0,001 соответственно). У пациентов с полными съемными зубными протезами после применения фиксирующего крема Протефикс Premium отмечалось более выраженное повышение уровня качества жизни. Независимо от наличия или отсутствия опыта использования других адгезивных средств также отмечалась положительная динамика уровня качества жизни (p<0,05). Премиальный фиксирующий крем нового поколения Протефикс Premium отвечает всем заявленным характеристикам производителя и может быть рекомендован для повседневного использования пациентам со съемными зубными протезами для повышения качества жизни. Various adhesive creams are used to improve the comfort of wearing removable dentures. There are many of their different types on the market, which makes it difficult for patients to choose. Now there is a new generation of Protefix Premium fixation cream, which has seven important properties. The aim is to evaluate the effect of the new generation Protefix Premium fixation cream on the quality of life of patients with removable dentures. . A total of 83 patients from 60 to 74 years of age with partial or complete adentia using partial or complete dentures participated in the study. All patients were prescribed Protefix Premium fixing cream for everyday use. We evaluated the dynamics of the patients' quality of life at the beginning of the study and after 30 days of Protefix Premium application. The quality of life was determined by the OHIP-14 questionnaire for assessing the quality of life of dental patients. . Statistically significant differences in the dynamics of the quality of life depending on the type of construction on the upper and lower jaw were obtained (p=0.004 and p=0.001, respectively). Patients with full removable dentures had a more pronounced increase in the quality of life after the use of Protefix Premium fixation cream. Regardless of the presence or absence of experience with other adhesive agents, a positive dynamics of the quality of life level was also noted (p<0,05). . The new-generation Protefix Premium adhesive cream meets all the manufacturer's stated characteristics and can be recommended for daily use by patients with removable dentures to improve quality of life.

29 March 2026 in Ophthalmology in Russia
Verified
Journal Article
Open access
PDF file
NSN. A. Sakhovskaya
N. A. Sakhovskaya
MFM. A. Frolov
M. A. Frolov
KKK. A. Kazakova
K. A. Kazakova
VLV. S. Luchin
V. S. Luchin
IVI. V. Vorobyeva
I. V. Vorobyeva
AFAleksandr Frolov
Aleksandr Frolov
Dry eye syndrome is a global problem of the modern world. Overload of information, rapid urbanization, and a busy lifestyle lead to non-compliance with work and rest schedules, including increased visual loads, decreased stress resistance in conditions of time deficit, leading to a deficiency of vital substances in the body. All the above are risk factors for the development of dry eye syndrome and affect the course of this disease. It is a well-known fact that balanced nutrition, regular intake of vitamins and microelements with food, and compliance with work and rest schedules play a role in the prevention and elimination of clinical manifestations of these conditions. This article presents the results of using the biologically active food supplement “DOPPELHERZ® V.I.P. OFTALMOVIT No. 30” (manufacturer Queisser Pharma GmbH & Co. KG, Germany) in the treatment of dry eye syndrome. The purpose of the study:  to evaluate the effect of the dietary supplement “DOPPELHERZ® V.I.P. OFTALMOVIT no. 30” in the treatment of dry eye syndrome. Material and methods. The study included 90 students with dry eye syndrome, aged 18 to 26 years. Patients of group I (control) did not receive any dietary supplements; group II (study group) received the dietary supplement “DOPPELHERZ® V.I.P. OFTALMOVIT”. Results. OSDI questionnaire — in the study group, the severity of dry eye syndrome: “before” moderate n  = 38, severe n  = 22, “1 month” moderate n  = 43, severe n  = 17, “2 months” mild n  = 11, moderate n  = 43, severe n  = 6, in the control group no changes ( p  = 0.368). Norn’s test: the study group showed an increase in tear film breakup time ( p  < 0.001), no changes were recorded in the control group ( p  = 0.285). Lacrimal meniscus height: the study group showed an increase in the height of the lacrimal meniscus, which indicates an improvement in the functional properties of the tear film and a decrease in dry eye syndrome ( p  < 0.001), no changes were recorded in the control group ( p  = 0.105). Schirmer tests 1 and 2: the study group showed an increase in the tear film breakup time, which indicates an improvement in the functional properties of the tear film and a decrease in dry eye syndrome, no changes were recorded in the control group (RSH1 = 0.587, RSH2 = 0.293). CISS questionnaire: a gradual decrease in the severity of asthenopia signs was observed in the study group ( p  < 0.001), no changes were recorded in the control group ( p  = 0.125). Pupillography: in the study group, regression of accommodation tension was recorded, more pronounced after 2 months ( p  < 0.001), in the control group there was a change in accommodation tension, which can be associated with the alternating predominance of sympathetic and parasympathetic wagging ( p  < 0.05). Discussion.  The concept of dry eye syndrome treatment includes etiopathogenetic, non-specific and symptomatic therapy. An integral link in the strategy of pathogenetic treatment of dry eye syndrome is the targeted introduction of vitamins and microelements into the diet. Conclusion. Based on the results of the study, as well as on the data of foreign and domestic authors, dietary supplements can serve as an additional source of vitamins and microelements, the deficiency of which is one of the components of the causes of dry eye syndrome pathogenesis. Considering the above, we can recommend taking the dietary supplement “DOPPELHERTS ® V.I.P. OFTALMOVIT” 1 capsule once a day for 2 months in the complex therapy of patients with dry eye syndrome.